510(k) Report

510(k) · Cleared

Recalled · Class II · 2020

Callos Impact and Inject Bone Void Filler

K051123510(k) SpecialCleared Jun 3, 200531-day reviewClass II21 CFR 888.3045Recalls 17

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Skeletal Kinetics, LLC · MQV Filler, Bone Void, Calcium Compound

Cleared on Jun 3, 2005 as substantially equivalent to K030554 (Skeletal Kinetics, LLC, 2003) after a 31-day review. Its family tree reaches back 2 generations to 2001. 9 later devices descend from it. It has been recalled 17 times.

Decided
Jun 3, 2005
Review
31 days
Class
Class II
Product code
MQV
Recalls
17
Predicates
1

Its longest line of descent runs back 2 generations to K011897 (2001). 9 later devices descend from it, 5 citing it directly.

Descendants, by year cleared 2010: 1 descendant cleared2012: 1 descendant cleared2005: 1 descendant cleared2014: 1 descendant cleared2020: 1 descendant cleared2017: 1 descendant cleared2021: 2 descendants cleared2019: 1 descendant clearedK011897 · Norian SRS Bone Void Filler · Synthes (Usa) · 2001K030554 · Callos · Skeletal Kinetics, LLC · 2003200020052010201520202025
Descendants, by generation 1 generation forward: 5 descendants2 generations forward: 3 descendants3 generations forward: 1 descendant K030554 · Callos · Skeletal Kinetics, LLC · 2003K011897 · Norian SRS Bone Void Filler · Synthes (Usa) · 20010
  1. Root · 2 generations backK011897 Norian SRS Bone Void FillerSynthes (Usa) · 2001
  2. 1 generation backK030554 CallosSkeletal Kinetics, LLC · 2003
  3. This deviceK051123 Callos Impact and Inject Bone Void FillerSkeletal Kinetics, LLC · 2005
  4. Descendant · cites it directly · 2 of its ownK051784 Osteovation CMF Bone Void FillerSkeletal Kinetics, LLC · 2005 · Recalled
  5. Descendant · 2 generations on · 1 of its ownK162864 OsteoVation ImpactSkeletal Kinetics, LLC · 2017 · Recalled
  6. Descendant · cites it directly · 1 of its ownK132211 Skaffold NMX Bone Void FillerSkeletal Kinetics, LLC · 2014
  7. Descendant · cites it directly · 1 of its ownK112383 Callos Promodel Bone Void Filler, Skaffold MP (Macro Porous) Bone…Skeletal Kinetics, LLC · 2012 · Recalled
  8. Descendant · 2 generations on · 0 of its ownK212353 DB-EZ Bone Void FillerDimensional Bioceramics, LLC · 2021

Showing 5 of 9 descendants. See all descendants

Descendants cleared per year

2005: 12010: 12012: 12014: 12017: 12019: 12020: 12021: 2
2005high 2 (2021) · low 0 (2006)2026

Most influential descendants

Showing 5 of 9 · See all
  • K051784Osteovation CMF Bone Void FillerSkeletal Kinetics, LLC · 2005 · cites it directly2descendants
  • K162864OsteoVation ImpactSkeletal Kinetics, LLC · 2017 · 2 generations on1descendant
  • K132211Skaffold NMX Bone Void FillerSkeletal Kinetics, LLC · 2014 · cites it directly1descendant
  • K112383Callos Promodel Bone Void Filler, Skaffold MP (Macro Porous) Bone Void FillerSkeletal Kinetics, LLC · 2012 · cites it directly1descendant
  • K212353DB-EZ Bone Void FillerDimensional Bioceramics, LLC · 2021 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K011897Norian SRS Bone Void FillerSynthes (Usa)2001—
−1K030554CallosSkeletal Kinetics, LLC2003—
0 (this device)K051123Callos Impact and Inject Bone Void FillerSkeletal Kinetics, LLC2005—
+1K051784Osteovation CMF Bone Void FillerSkeletal Kinetics, LLC200513
+2K162864OsteoVation ImpactSkeletal Kinetics, LLC20177
+1K132211Skaffold NMX Bone Void FillerSkeletal Kinetics, LLC2014—
+1K112383Callos Promodel Bone Void Filler, Skaffold MP (Macro Porous) Bone Void FillerSkeletal Kinetics, LLC20123
+2K212353DB-EZ Bone Void FillerDimensional Bioceramics, LLC2021—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200510
201010
201210
201410
201710
201910
202010
202120
FIG. 1 — Lineage of K051123, 2001–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MQV device

  1. #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K030554Callos
Summary page 1
…Bone Void Filler Classification Name: 87 MVQ Predicate Devices Callos Bone Void Filler K030554; cleared on May 20, 2003 Product Description Callos is a calcium phosphate bone void filler which can either be injected or dig…
Skeletal Kinetics, LLC2003—

Also cleared against K030554: 2 other devices →

What descends from it? (9)

5 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K051784Osteovation CMF Bone Void FillerSkeletal Kinetics, LLC20052
K132211Skaffold NMX Bone Void FillerSkeletal Kinetics, LLC20141
K112383Callos Promodel Bone Void Filler, Skaffold MP (Macro Porous) Bone Void FillerSkeletal Kinetics, LLC20121
K200752DB-OrthopedicsDimensional Bioceramics, LLC20200
K100986Callos Bone Void Filler, Skaffold Next Generation Bone Void Filler, Osteo VationSkeletal Kinetics, LLC20100

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Apr 6, 2020Class IIZ-2622-2020Under Investigation by firmBone void filler kits may not maintain its setting characteristics for the labeled shelf-life duration. Use may increase the required surgical and anesthesia time for the patient or possible longer-term health consequences could include…
Apr 6, 2020Class IIZ-2620-2020Under Investigation by firmBone void filler kits may not maintain its setting characteristics for the labeled shelf-life duration. Use may increase the required surgical and anesthesia time for the patient or possible longer-term health consequences could include…
Apr 6, 2020Class IIZ-2606-2020Under Investigation by firmBone void filler kits may not maintain its setting characteristics for the labeled shelf-life duration. Use may increase the required surgical and anesthesia time for the patient or possible longer-term health consequences could include…
Apr 6, 2020Class IIZ-2623-2020Under Investigation by firmBone void filler kits may not maintain its setting characteristics for the labeled shelf-life duration. Use may increase the required surgical and anesthesia time for the patient or possible longer-term health consequences could include…
Apr 6, 2020Class IIZ-2610-2020Under Investigation by firmBone void filler kits may not maintain its setting characteristics for the labeled shelf-life duration. Use may increase the required surgical and anesthesia time for the patient or possible longer-term health consequences could include…
Apr 6, 2020Class IIZ-2593-2020Under Investigation by firmBone void filler kits may not maintain its setting characteristics for the labeled shelf-life duration. Use may increase the required surgical and anesthesia time for the patient or possible longer-term health consequences could include…
Apr 6, 2020Class IIZ-2607-2020Under Investigation by firmBone void filler kits may not maintain its setting characteristics for the labeled shelf-life duration. Use may increase the required surgical and anesthesia time for the patient or possible longer-term health consequences could include…
Apr 6, 2020Class IIZ-2592-2020Under Investigation by firmBone void filler kits may not maintain its setting characteristics for the labeled shelf-life duration. Use may increase the required surgical and anesthesia time for the patient or possible longer-term health consequences could include…
Apr 6, 2020Class IIZ-2594-2020Under Investigation by firmBone void filler kits may not maintain its setting characteristics for the labeled shelf-life duration. Use may increase the required surgical and anesthesia time for the patient or possible longer-term health consequences could include…
Apr 6, 2020Class IIZ-2621-2020Under Investigation by firmBone void filler kits may not maintain its setting characteristics for the labeled shelf-life duration. Use may increase the required surgical and anesthesia time for the patient or possible longer-term health consequences could include…
Apr 6, 2020Class IIZ-2611-2020Under Investigation by firmBone void filler kits may not maintain its setting characteristics for the labeled shelf-life duration. Use may increase the required surgical and anesthesia time for the patient or possible longer-term health consequences could include…
Apr 2, 2020Class IIZ-2181-2020Vendor change controlIncorrect shelf-life for bone void filler kits; the product may not maintain its setting characteristics for the labeled shelf-life duration.
Apr 2, 2020Class IIZ-2182-2020Vendor change controlIncorrect shelf-life for bone void filler kits; the product may not maintain its setting characteristics for the labeled shelf-life duration.
Apr 2, 2020Class IIZ-2183-2020Vendor change controlIncorrect shelf-life for bone void filler kits; the product may not maintain its setting characteristics for the labeled shelf-life duration.
Apr 2, 2020Class IIZ-2184-2020Vendor change controlIncorrect shelf-life for bone void filler kits; the product may not maintain its setting characteristics for the labeled shelf-life duration.
Apr 2, 2020Class IIZ-2180-2020Vendor change controlIncorrect shelf-life for bone void filler kits; the product may not maintain its setting characteristics for the labeled shelf-life duration.
May 29, 2015Class IIZ-2209-2015No Marketing ApplicationReports of venous uptake, DVT, pulmonary embolism in patients who were implanted with Injection Plasty Bone Void Filler.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 4 years and passes through 2 companies; a new generation was cleared every 2.0 years on median.
  • None of the 2 ancestors has a recall.
  • Of its descendants, K051784 (Skeletal Kinetics, LLC, 2005) has gone furthest, with 2 descendants of its own.
  • 2 other devices also cite its predicate K030554.

How does its category compare?

All MQV devices

MQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MQV

14in 2025

2007: 352008: 322009: 232010: 172011: 162012: 92013: 122014: 202015: 182016: 82017: 172018: 232019: 132020: 152021: 82022: 92023: 212024: 282025: 142026 (partial year): 5
2007high 35 (2007) · low 8 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MQV

57in 2025

2007: 144 days median2008: 102 days median2009: 180 days median2010: 147 days median2011: 92 days median2012: 107 days median2013: 197 days median2014: 153 days median2015: 184 days median2016: 214 days median2017: 124 days median2018: 124 days median2019: 90 days median2020: 132 days median2021: 88 days median2022: 118 days median2023: 74 days median2024: 55 days median2025: 57 days median2026 (partial year): 96 days median
2007high 214 (2016) · low 55 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MQV

1in 2025

2007: 52008: 32009: 12011: 62012: 32013: 22016: 12017: 12018: 22020: 12023: 32024: 22025: 12026 (partial year): 4
2007high 6 (2011) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MQV

57in 2025

2007: 672008: 712009: 812010: 682011: 1142012: 1492013: 2232014: 1112015: 1252016: 1062017: 1072018: 862019: 652020: 1262021: 1012022: 472023: 1202024: 682025: 57
2007high 223 (2013) · low 47 (2022)2025

MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200735144567
200832102371
200923180181
201017147068
201116926114
201291073149
2013121972223
2014201530111
2015181840125
201682141106
2017171241107
201823124286
20191390065
2020151321126
20218880101
20229118047
202321743120
20242855268
20251457157
20265964—

What is it indicated for?

Callos is indicated to fill bony voids or gaps of the skeletal system (i.e. extremities, spine, pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. Callos Bone Void Filler is indicated only for bony voids or gaps that are not intrinsic to the stability of the bony structure. The product provides a bone void filler that resorbs and is replaced by bone during the healing process.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K051123: Callos Impact and Inject Bone Void Filler.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K051123

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026